Published by Josh White on 31st May 2019
(Sharecast News) - Liquid biopsy company Angle announced positive results from its 'Parsortix' FDA clinical study for metastatic breast cancer on Friday.
URL: http://www.digitallook.com/dl/news/story/29106935/...